1. Bulatova I.A., Shhjokotova A.P., Dolgih O.V., Paducheva S.V. Citokinovyi status u bol’nykh tsirrozami pecheni raznoi etiologii [Cytokine status in patients with cirrhosis of the liver of different etiology]. Sovremennye problemy nauki i obrazovaniya, 2016, no. 3. Available at: www.science-education.ru/ru/article/view?id=24755 (Accessed 13.08.2020).
2. Toneeva M.A., Kulikov V.E. Vzaimosvyaz’ mezhdu kolichestvennymi parametrami pecheni i urovnyami tsitokinov u pacientov s cirrozami pecheni virusnoi etiologii [Relationship between quantitative parameters of the liver and cytokine levels in patients with cirrhosis of the liver of viral etiology]. Ul’trazvukovaja i funkcional’naja diagnostika, 2015, no. 5S, p. 173a.
3. Albillos A., Lario M., Álvarez-Mon M. Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance. J Hepatol., 2014, vol. 61, pp. 1385–1396.
4. Angeli P., Merkel C. Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis. J Hepatol., 2008, vol. 48, Suppl 1, pp. S93–S103.
5. Antoniades C.G., Khamri W., Abeles R.D., Taams L.S., Triantafyllou E., Possamai L.A. et al. Secretory leukocyte protease inhibitor: A pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure. Hepatology, 2014, vol. 59, pp. 1564–1576.